Letter: Cardiovascular Risk in Prostate Cancer Patients Using Luteinizing Hormone‒Releasing Hormone Agonists or a Gonadotropin-Releasing Hormone Antagonist

J Urol. 2024 Mar;211(3):481. doi: 10.1097/JU.0000000000003830. Epub 2023 Dec 22.

Authors

Jordi Stira¹, Carmen Gravina¹, Riccardo Lombardo¹, Cosimo De Nunzio¹

Affiliation

¹ Azienda Ospedaliero-Universitaria Sant'Andrea, Sapienza, Università di Roma.

PMID: 38131355
DOI: 10.1097/JU.0000000000003830

No abstract available

Publication types

Letter

MeSH terms

Cardiovascular Diseases* / chemically induced
Cardiovascular Diseases* / epidemiology
Gonadotropin-Releasing Hormone
Heart Disease Risk Factors
Humans
Male
Prostatic Neoplasms* / drug therapy
Risk Factors

Substances

Gonadotropin-Releasing Hormone